Third Harmonic Bio, Inc.
THRDDelisted Jul 31, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001923840
Third Harmonic Bio, Inc. was delisted on Jul 31, 2025; its insiders filed their last Form 4 on Aug 14, 2025; 107 institutions reported holding it in 13F filings for Q2 2025, worth $210.2M in total; no superinvestor held it.
13F holders, Q3 2023
Institutional positions in Third Harmonic Bio, Inc. as of Sep 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 56
- +8 vs. Q2 2023
- Shares held
- 37.8M
- +1.73M (+4.8%) vs. Q2 2023
- Total value
- $241.5M
- +$68.0M (+39.2%) vs. Q2 2023
- New holders
- 11
- 18 more added
- Sold out
- 3
- 11 more reduced
Compare with Q2 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting THRD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 4 | $110.0K |
| Q1 2026 | 4 | $110.0K |
| Q4 2025 | 4 | $111.5K |
| Q3 2025 | 18 | $1.19M |
| Q2 2025 | 107 | $210.2M |
| Q1 2025 | 100 | $134.4M |
| Q4 2024 | 98 | $462.5M |
| Q3 2024 | 85 | $596.6M |
| Q2 2024 | 77 | $523.2M |
| Q1 2024 | 71 | $357.6M |
| Q4 2023 | 62 | $416.0M |
| Q3 2023 | 56 | $241.5M |
| Q2 2023 | 48 | $173.5M |
| Q1 2023 | 49 | $149.7M |
| Q4 2022 | 50 | $153.1M |
| Q3 2022 | 40 | $672.8M |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2023
Shares, value and share of portfolio for each institution holding Third Harmonic Bio, Inc.; share changes are against Q2 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 44 | $0 | 0.00% | 00.0% | Unchanged |
| Citigroup Inc | 9 | $58 | 0.00% | −5,792−99.8% | Reduced |
| Toronto Dominion Bank | 31 | $198 | 0.00% | 00.0% | Unchanged |
| Nisa Investment Advisors, LLC | 137 | $875 | 0.00% | +100+270.3% | Added |
| Glassman Wealth Services | 149 | $952 | 0.00% | 00.0% | Unchanged |
| Covestor Ltd | 207 | $1.00K | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 320 | $2.04K | 0.00% | +320 | New |
| Ameritas Investment Partners, Inc. | 1,010 | $6.45K | 0.00% | 00.0% | Unchanged |
| Metropolitan Life Insurance Co | 1,255 | $8.02K | 0.00% | +1,255 | New |
| Legal & General Group Plc | 1,816 | $11.6K | 0.00% | 00.0% | Unchanged |
| Amalgamated Bank | 2,037 | $13.0K | 0.00% | +1,313+181.4% | Added |
| Tower Research Capital LLC (TRC) | 2,140 | $13.7K | 0.00% | −3,472−61.9% | Reduced |
| STRS Ohio | 2,900 | $18.0K | 0.00% | 00.0% | Unchanged |
| The PNC Financial Services Group, Inc. | 2,981 | $19.0K | 0.00% | +2,441+452.0% | Added |
| FMR LLC | 3,445 | $22.0K | 0.00% | +693+25.2% | Added |
| Barclays PLC | 3,510 | $22.4K | 0.00% | −450−11.4% | Reduced |
| Royal Bank of Canada | 3,627 | $23.0K | 0.00% | +1,501+70.6% | Added |
| California State Teachers Retirement System | 4,298 | $27.5K | 0.00% | −2,182−33.7% | Reduced |
| Wells Fargo & Company | 4,793 | $30.6K | 0.00% | −2,570−34.9% | Reduced |
| Annapolis Financial Services, LLC | 5,000 | $31.9K | 0.01% | +5,000 | New |
| New York State Common Retirement Fund | 5,018 | $32.1K | 0.00% | −9,396−65.2% | Reduced |
| Allspring Global Investments Holdings, LLC | 7,309 | $46.7K | 0.00% | +6,977+2,101.5% | Added |
| American International Group, Inc. | 9,722 | $62.1K | 0.00% | +346+3.7% | Added |
| CIBC Asset Management Inc | 10,573 | $67.6K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 10,646 | $68.0K | 0.00% | −613−5.4% | Reduced |
| MetLife Investment Management | 11,604 | $74.2K | 0.00% | +11,604 | New |
| JPMorgan Chase & Co | 12,960 | $82.8K | 0.00% | −2,564−16.5% | Reduced |
| Deutsche Bank AG | 14,527 | $92.8K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 16,397 | $104.8K | 0.01% | +555+3.5% | Added |
| Rhumbline Advisers | 18,628 | $119.0K | 0.00% | +1,841+11.0% | Added |
| Bank of America Corp | 19,553 | $124.9K | 0.00% | −799−3.9% | Reduced |
| Nuveen Asset Management, LLC | 26,824 | $171.4K | 0.00% | 00.0% | Unchanged |
| Jacobs Levy Equity Management, Inc | 33,428 | $213.6K | 0.00% | +33,428 | New |
| Bank of New York Mellon Corp | 57,550 | $367.7K | 0.00% | +4,197+7.9% | Added |
| Bridgeway Capital Management, LLC | 89,100 | $569.3K | 0.01% | 00.0% | Unchanged |
| Morgan Stanley | 106,525 | $680.7K | 0.00% | −26,593−20.0% | Reduced |
| UBS Oconnor LLC | 125,000 | $798.8K | 0.01% | +125,000 | New |
| Charles Schwab Investment Management Inc | 126,855 | $810.6K | 0.00% | +23,585+22.8% | Added |
| Northern Trust Corp | 154,110 | $984.8K | 0.00% | +9,238+6.4% | Added |
| Adage Capital Partners GP, L.L.C. | 192,027 | $1.23M | 0.00% | +192,027 | New |
| Atika Capital Management LLC | 203,199 | $1.30M | 0.18% | +203,199 | New |
| State Street Corp | 278,133 | $1.78M | 0.00% | +13,430+5.1% | Added |
| DAFNA Capital Management LLC | 300,000 | $1.92M | 0.60% | +300,000 | New |
| Geode Capital Management, LLC | 361,155 | $2.31M | 0.00% | +44,480+14.0% | Added |
| Boxer Capital, LLC | 520,417 | $3.33M | 0.18% | −50,000−8.8% | Reduced |
| Vanguard Group Inc | 773,458 | $4.94M | 0.00% | +3,615+0.5% | Added |
| Ra Capital Management, L.P. | 961,863 | $6.15M | 0.12% | +961,863 | New |
| BlackRock Inc. | 1,157,119 | $7.39M | 0.00% | +82,549+7.7% | Added |
| Braidwell LP | 1,653,991 | $10.6M | 0.33% | +1,653,991 | New |
| Commodore Capital LP | 1,700,000 | $10.9M | 1.27% | +706,706+71.1% | Added |
| Tang Capital Management LLC | 1,800,000 | $11.5M | 1.62% | 00.0% | Unchanged |
| General Atlantic LLC | 2,958,762 | $18.9M | 0.29% | 00.0% | Unchanged |
| EcoR1 Capital, LLC | 2,982,444 | $19.1M | 0.65% | +893,664+42.8% | Added |
| BVF Inc | 4,365,933 | $27.9M | 0.75% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 5,779,071 | $36.9M | 0.85% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 10,907,859 | $69.7M | 10.80% | 00.0% | Unchanged |
| Stonepine Capital Management, LLC | 0 | $0 | 0.00% | −2,793,149−100.0% | Sold out |
| Bain Capital Life Sciences Investors, LLC | 0 | $0 | 0.00% | −640,631−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −16,460−100.0% | Sold out |